James Shin
Stock Analyst at Deutsche Bank
(2.48)
# 2,438
Out of 4,981 analysts
22
Total ratings
50%
Success rate
4.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $749.75 | +20.04% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $5.73 | +74.52% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $112.83 | +6.35% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $81.40 | +28.99% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $273.76 | +11.41% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $83.48 | -28.13% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $46.34 | -2.89% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $33.43 | +79.48% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $217.19 | -30.94% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $573.66 | +39.46% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.33 | +651.88% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.88 | +1,260.39% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $749.75
Upside: +20.04%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $5.73
Upside: +74.52%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $112.83
Upside: +6.35%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $81.40
Upside: +28.99%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $273.76
Upside: +11.41%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $83.48
Upside: -28.13%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $46.34
Upside: -2.89%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $33.43
Upside: +79.48%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $217.19
Upside: -30.94%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $573.66
Upside: +39.46%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.88
Upside: +1,260.39%